Stay updated on Tivozanib Plus Nivolumab in RCC: Clinical Trial
Sign up to get notified when there's something new on the Tivozanib Plus Nivolumab in RCC: Clinical Trial page.

Latest updates to the Tivozanib Plus Nivolumab in RCC: Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision label changed from v3.6.0 to v3.6.3, indicating a newer page version. This reflects a deployment or maintenance update rather than changes to study details.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). A recruitment status update ('No longer looking for participants') indicates enrollment has closed, the page was updated to Revision: v3.6.0, and minor formatting changes were applied to the Intervention/Treatment label.SummaryDifference0.5%

- Check32 days agoChange DetectedThe page footer revision label was updated from v3.5.4 to v3.5.5. This reflects a routine CMS update and does not change the visible content.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new build deployment. This update reflects a platform-level change rather than modifications to the study details content.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a minor technical/version update without changing the study information.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Tivozanib Plus Nivolumab in RCC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tivozanib Plus Nivolumab in RCC: Clinical Trial page.